UAE ranks third in pulmonary fibrosis treatment
The Emirates Pharmaceutical Foundation announced the approval of the drug "Jascaid" for the treatment of pulmonary fibrosis, making the UAE the third country worldwide and the first region to approve this therapy after the United States and China. The approval came after a comprehensive scientific and regulatory evaluation, strengthening the healthcare system and providing modern treatment options for adult patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)